TSG Therapeutics

TSG Therapeutics is a biopharmaceutical company that is pioneering innovative medicines for the treatment and prevention of viral infectious diseases, especially neglected ones. TSG is developing high-impact, value-based medicines that work against mosquito-borne viral infections including Zika, Dengue, Yellow Fever, Japanese Encephalitis, and Chikungunya, as well as other currently intractable viral infections such as those caused by Rabies virus. Whereas conventional approaches are based on a narrow “one bug, one drug” concept, TSG’s technology is driven by a broad-spectrum vision that will lead to cures for a wide range of viral infections affecting millions of people worldwide annually.